Amgen recalls anemia drugs
Amgen Inc. is recalling some lots of its blockbuster Epogen and Procrit anemia treatments because the injected drugs may contain glass flakes that could cause blood clots, swelling of veins, immune system reactions and other problems.
The Thousand Oaks biotechnology company said that the flakes were barely visible in most cases and that it had fielded no complaints or reports about problems that could be directly tied to them. Patients experiencing problems should contact their doctor.
Amgen said the flakes were caused by the drugs’ interaction with glass vials over the products’ shelf life.